COMMUNIQUÉS West-GlobeNewswire

Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:05

MEDFORD, N.Y., March 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the fourth [...]

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights

08/03/2018 - 22:05

Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today reported financial results for the fourth [...]

Yield10 Bioscience Announces Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:04

WOBURN, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]

MyoKardia Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:03

Announced Achievement of Primary Endpoint and Additional Key Data from Low-Dose Mavacamten Cohort of PIONEER-HCM Phase 2 Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Company to Host Conference Call and [...]

MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

08/03/2018 - 22:02

Met Primary Endpoint and Key Secondary Endpoints with Statistical Significance Study Results Inform Phase 3 EXPLORER-HCM Dosing; First Patient Planned for Q2 2018 Conference Call Today at 4:30 p.m. ET (1:30 p.m. PT); [...]

Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:01

MORRISTOWN, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, announced today financial results for the three and twelve months ended [...]

Flexion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:01

Early launch activities for ZILRETTA ® progressing well (strong clinical interest from prescribers; broad coverage from payers; encouraging feedback from patients) Company booked net ZILRETTA sales of approximately $ [...]

ChromaDex Corporation Reports 2017 Financial Results

08/03/2018 - 22:01

IRVINE, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to improving the way people age, announced today fourth quarter and [...]

Global Blood Therapeutics Announces Proposed Public Offering of Common Stock

08/03/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT ), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing [...]

Capricor Therapeutics to Present Fourth Quarter and Full Year 2017 Financial Results and Corporate Update on Wednesday, March 14

08/03/2018 - 22:00

LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]

Coherus BioSciences Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:00

REDWOOD CITY, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today reviewed corporate events and reported financial results for the quarter and full year ended December 31, 2017. [...]

Medtronic EVP & CVG President Mike Coyle to Speak at Cowen Healthcare Conference

08/03/2018 - 20:30

DUBLIN - March 8, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the 38 th Annual Cowen and Company Healthcare Conference on Tuesday, March 13, 2018, [...]

Daxor Corporation Announces Rise in Kit Sales, New Device Sale, and Filing of Form N-CSR for 2017 (NYSE MKT LLC: DXR)

08/03/2018 - 18:56

New York, NY, March 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, filed a Form N-CSR disclosing its schedule of [...]

Saratoga Springs Plastic Surgeon Named 2018 “Top Doctor” in Albany, NY Metro Area

08/03/2018 - 17:42

SARATOGA SPRINGS, N.Y., March 08, 2018 (GLOBE NEWSWIRE) -- Saratoga Springs Plastic Surgery, PC recently announced that Dr. Steven Yarinsky was named a 2018 “Top Doctor” for the Albany, Capital District and New York [...]

Patient Home Monitoring Announces Date and Time for Quarterly Conference Call

08/03/2018 - 17:11

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, March 08, 2018 (GLOBE NEWSWIRE) -- Patient Home [...]

Creating Long-Term Value for Our Members

08/03/2018 - 17:00

TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) announced today that its Funded Status at the end of 2017 was 122%, unchanged from the prior year. The Fund’s net assets reached [...]

OncBioMune Selects Theradex as CRO for Two Phase 2 Trials of ProscaVax for Prostate Cancer

08/03/2018 - 15:15

BATON ROUGE, La., March 08, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

08/03/2018 - 15:04

BURLINGAME, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and [...]

Sanofi Completes Acquisition of Bioverativ Inc.

08/03/2018 - 15:00

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Completes Acquisition of Bioverativ Inc. Bioverativ Inc. is a fully owned subsidiary of Sanofi Paris (France) - March 8, 2018 - Sanofi announced today the [...]